AGENDA
| Activity | Time |
| Registration Poster installation Exhibitors’ setup |
09:00 – 14:00 |
| SPEAKER | TITLE | TIME |
| Prof. Paolo Martelli (University Rector) Francesca Buttini (University of Parma) |
Conference opening: Welcome and Introduction | 14:00-14:20 |
|
NEW PARADIGMS IN LUNG DELIVERY
|
||
|
Chairs: Ruggeto Bettini and Joanne Peart |
||
|
Keynote Speaker: Melanie Ott |
In the Air Around Us: Understanding and Outpacing Viral Threats | 14:20 – 15:00 |
| Vivek Lal (Alveolus Bio) |
Inhaled Biotherapeutics: Creating First-in-Class Therapies for Chronic Respiratory Illnesses |
15:00 – 15:25 |
| Philip Kwok (University of Sidney) |
Probiotic-bacteriophage aerosols for treating bacterial lung infections |
15:25 – 15:50 |
|
COFFEE BREAK + POSTER SESSION |
||
|
Chairs: Julie Suman and Francesca Buttini |
||
| Michael Goller (TranspireBio) |
Expanding Inhalation Therapies beyond Asthma and COPD | 16:30 – 16:55 |
| Andrea Casazza (Chiesi Farmaceutici) |
The Therapeutic Pipeline in Respiratory Diseases | 16:55 – 17:20 |
| Miles Kottman (Bespak) |
Beyond the propellant: taking the next step in low carbon pMDIs |
17:20 – 17:30 |
| Lucas Silva (Aptar Pharma) |
Breaking Barriers in Biologics Delivery: Advanced Nasal and Pulmonary Delivery of Large Proteins and Nucleic Acids |
17:30 – 17:40 |
|
WELCOME RECEPTION (17:40 – 19:00)
|
||
|
AEROSOLS OF LUNG INFECTION
|
||
|
Chairs: Irene Rossi |
||
| Sara Maloney (RTI International) |
Formulation Strategies for Inhaled NTM Therapies | 09:00 – 09:25 |
| Mercedes Gonzalez-Huarrero (Colorado University) |
Preclinical development of aerosol therapy for M. abscessus pulmonary disease | 09:25 – 09:50 |
| Verma (Institute of Nano Science and Technology Mohali) |
Inhalable self-propelled Autonomous micro motors for Tuberculosis therapeutics |
09:50 – 10:05 |
| Anselm Ebert (H&T Presspart) |
Navigating Inhalation Trends: Delivering Innovative, Sustainable Device Solutions |
10:05 – 10:15 |
|
COFFEE BREAK + POSTER SESSION |
||
|
PRESSURISED METERED DOSE INHALES AT 70
|
||
|
Chairs: Paul Young and Geraldine Venthoye |
||
| John Pritchard (Inspiring Strategies) |
Is the transition to lower global-warming propellants on schedule? | 11:00 – 11:20 |
| Sheryl Johnson (Orbia) |
pMDI Formulation at 70: Unlocking HFA 152a for the Next Generation | 11:20 – 11:30 |
| Mark Boelens (Solstice) |
Evolving Regulatory Landscape for the Adoption of Low Global Warming Potential (LGWP) Propellants |
11:30 – 11:40 |
| David Lewis (Oz-Uk Ltd) |
From First Principles to Representative Performance: pMDIs in the Low-GWP Era | 11:40 – 12:00 |
| Stephen Stein (CGT Pharma Consulting) |
Developing Suitable Suspension MDI Formulations in LGWP Propellants | 12:00 – 12:20 |
| ROUND TABLE |
1000 Years of Experience, 16 Years of Progress: What Still Remains? David Lewis – John Pritchard – Nick Smalley (Kindeva) – Stephen Stein |
12:20 – 13:00 |
|
LIGHT LUNCH + POSTER SESSION |
||
|
MUCUS PENETRATING PARTICLES AND RNA DELIVERY
|
||
|
Chairs: Ayca Jildiz and Ben Forbes |
||
| Keynote Speaker Justin Hanes (Johns Hopkins University) |
The Airway Mucus Barrier and How to Overcome it | 14:15 – 14:55 |
| Rémi Rosière (InhaTarget Therapeutics) |
Lung Delivery of Nucleic Acid–Loaded Lipid Nanoparticles to Tackle High Unmet Needs in Respiratory Medicine | 14:55 – 15:20 |
| Koen Raemdonck (Ghent University) |
Inhalable RNA formulations for pulmonary diseases | 15:20 – 15:45 |
|
COFFEE BREAK + POSTER SESSION |
||
|
PRECLINICAL MODELS AND DEVICE INNOVATION
|
||
|
Chairs: Alessandro Fioni and Daniela Traini |
||
| Philip Kuehl (Aptar Pharma) |
Preclinical Tools for Advancing Pulmonary and Nasal Drug Products | 16:15 – 16:40 |
| Dahlmann Franziska (Hannover Medical School) |
Translational development of an inhaled palmitoylconjugated antiviral siRNA against Human Parainfluenza infection |
16:40 – 17:05 |
| Murat Ali (Phillips Medisize) |
Enabling Therapies Today and Tomorrow: Demonstrating the Versatility of Blister-Based Dry Powder Inhalers for Current and Future Drug Delivery | 17:05 – 17:30 |
|
EMERGING PERSPECTIVES IN AIRWAY INFLAMMATION, CHRONIC COUGH AND BRONCHIECTASIS
|
||
|
Chairs: TBD |
||
| Keynote Speaker David Edwards (SC Therapeutics) |
Airway inflammation and hypertension | 09:00 – 09:40 |
| Federico Lavorini (Careggi University Hospital) |
Clinical Aspects and Pathophysiology of Chronic Cough | 09:40 – 10:05 |
| Alyn Morice (University of Hull) |
Chronic Cough Management: From Current Treatments to Emerging Therapies | 10:05 – 10:30 |
| Diletta Mandrioli (University of Parma) |
Carcainium Dry Powder Inhaler for Prolonged Chronic Cough Treatment | 10:30 – 10:45 |
|
COFFEE BREAK + POSTER SESSION |
||
| Stefano Aliberti (Humanitas Research Hospital) |
Non–cystic fibrosis bronchiectasis and emerging therapeutic strategies | 11:30 – 11:55 |
| Young Investigator in NCFB | ||
| ROUND TABLE |
1.000 years of experience, 16 years of progress: what still remains? Paolo Colombo (Plumestars) – Carsten Ehrhardt (Trinity College) – Ben Forbes (KCL) – Anthony Hickey (RTI) – John Patton (Kindeva) |
11:55 – 13:00 |
|
LIGHT LUNCH + POSTER SESSION |
||
NASAL DELIVERY OF BIOLOGICS AND RNA |
||
|
Chairs: Regina Scherliess & Fabio Sonvico |
||
| Nathalie Heuzé-Vourc’h (National Institute of Biomedical Research) |
Exploring Intranasal Delivery of Anti-Infective Antibodies | 14:30 – 14:55 |
| Chantelle Ahlenstiel (Kirby Institute) |
Respiratory delivery of antiviral RNA therapeutics | 14:55 – 15:20 |
| Katharina Schindowski (Biberach University) |
Intranasal nose-to-brain delivery of a monoclonal antibody with a controlled release drug delivery system: proof-ofconcept and pharmacokinetic studies in mini pigs | 15:20 – 15:45 |
|
COFFEE BREAK + POSTER SESSION |
||
|
Chairs: Philippe Rogueda |
||
| Ana Fortuna (University of Coimbra) |
From First Principles to Measured Performance: pMDIs in the Low-GWP Era | 16:15 – 16:30 |
| Brianna Walz (University of Toronto) |
Optimization and Mechanistic Characterization of Intranasal mRNA-Lipid Nanoparticles for Systemic Protein Secretion | 16:30 – 16:45 |
| Francesca Buttini (University of Parma) |
CLOSING REMARKS | 16:45 – 17:00 |
|
GALA DINNER |
||
CONFIRMED PLENARY SPEAKERS
David Edwards
SC Therapeutics, US
Justin Hanes
Johns Hopkins University, US
CONFIRMED INVITED SPEAKERS
Mercedes Gonzalez-Juarrero
Colorado State University, US
Michael Goller
Transpire Bio, US
Philip Kuehl
Aptar Pharma, US
Philip Kwok
University of Sydney, Australia
Vivek Lal
Alveolus Bio, US
David Lewis
Oz-UK Ltd, UK
Sara Maloney
RTI International, US
Alyn Morice
University of Hull, UK
John Pritchard
Inspiring Strategies, UK
Koen Raemdonck
Ghent University, Belgium
Rémi Rosière
InhaTarget Therapeutics, Belgium
Katharina Schindowski
Biberach University, Germany
Steve Stein
CGT Pharma Consulting, US
Nathalie Heuzé-Vourc’h
National Institute of Biomedical Research, France
SPEAKERS FROM OUR PLATINUM SPONSORS
Anselm Ebert
H&T Presspart
Mark Boelens
Solstice
Sheryl Johnson
Orbia
Miles Kottman
Bespak
Lucas Silva
Aptar Company
